Opening book details…
Can I read PSMA Radioligand Therapy: A Revolution in the Precision Radiomolecular Oncology of Prostate Cancer on EtoBox?
PSMA Radioligand Therapy: A Revolution in the Precision Radiomolecular Oncology of Prostate Cancer by Harshad R. Kulkarni is a book available to read on EtoBox.
What is PSMA Radioligand Therapy: A Revolution in the Precision Radiomolecular Oncology of Prostate Cancer about?
## Abstract The incidence of prostate cancer is ever increasing. After various time intervals, the disease almost always becomes resistant to the standard hormone treatment (castration-resistant prostate cancer, CRPC). Most patients with CRPC either already have metastases at diagnosis or develop them during the early months of follow-up, which is associated with a relatively poor prognosis. The taxane-based chemotherapy for metastatic CRPC (mCRPC), first line with docetaxel and second line using cabazitaxel, are associated with a high incidence of adverse effects. The novel androgen-axis drugs (NAAD) used after chemotherapy are androgen biosynthesis inhibitor abiraterone acetate (combined with prednisolone), the androgen receptor blockers enzalutamide as well as the newer generation apalutamide and darolutamide. However, these treatment regimens only provide a meager survival benefit in mCRPC. Radium-223 targets only the osteoblastic metastases and does not treat nodal or visceral metastases. Therefore, there has been an unmet need for targeted therapy.
- Author
- Harshad R. Kulkarni
- Publisher
- Springer International Publishing AG
- Published
- 2024
- Language
- EN
- ISBN
- 9783031335334
- Subjects
- Medical, Medicine
More by Harshad R. Kulkarni
Browse all works by Harshad R. Kulkarni
Similar books
- Evaluation of Real-World Efficiency of 177Lu-PSMA Radioligand Therapy of Metastatic Prostate Cancer — J. Harvey Turner (2024)
- Hormone Therapy and Castration Resistance of Prostate Cancer — Yōichi Arai; Osamu Ogawa (2018)
- Therapy of Castration-Resistant Prostate Cancer: Where Is the Place of 225Ac-PSMA? — Ismaheel O. Lawal; Alfred Morgenstern; Otto Knoesen; Mariza Vorster; Frank Bruchertseifer; Mike M. Sathekge (2024)
- Precision Oncology with PSMA-Targeted α-Particle Therapy of mCRPC — Hossein Jadvar (2024)
- Management of Prostate Cancer — Eric A. Klein (1995)
- Prostate Cancer : Understand the Disease and Its Treatment — Fred Saad, Michael McCormack (2015)